FI891581A0 - Peptidderivat. - Google Patents

Peptidderivat.

Info

Publication number
FI891581A0
FI891581A0 FI891581A FI891581A FI891581A0 FI 891581 A0 FI891581 A0 FI 891581A0 FI 891581 A FI891581 A FI 891581A FI 891581 A FI891581 A FI 891581A FI 891581 A0 FI891581 A0 FI 891581A0
Authority
FI
Finland
Prior art keywords
peptidderivat
ferm
excipient
chem
association
Prior art date
Application number
FI891581A
Other languages
English (en)
Other versions
FI891581A (fi
FI102547B (fi
FI102547B1 (fi
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI891581A0 publication Critical patent/FI891581A0/fi
Publication of FI891581A publication Critical patent/FI891581A/fi
Application granted granted Critical
Publication of FI102547B publication Critical patent/FI102547B/fi
Publication of FI102547B1 publication Critical patent/FI102547B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI891581A 1988-04-05 1989-04-03 Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä FI102547B1 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807921A GB8807921D0 (en) 1988-04-05 1988-04-05 Ws-9326 & its derivatives

Publications (4)

Publication Number Publication Date
FI891581A0 true FI891581A0 (fi) 1989-04-03
FI891581A FI891581A (fi) 1989-10-06
FI102547B FI102547B (fi) 1998-12-31
FI102547B1 FI102547B1 (fi) 1998-12-31

Family

ID=10634574

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891581A FI102547B1 (fi) 1988-04-05 1989-04-03 Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä

Country Status (20)

Country Link
EP (1) EP0336230B1 (fi)
JP (1) JP2551142B2 (fi)
KR (1) KR0132567B1 (fi)
CN (1) CN1037857C (fi)
AT (1) ATE148890T1 (fi)
AU (1) AU627453B2 (fi)
CA (1) CA1335662C (fi)
DE (1) DE68927759T2 (fi)
DK (1) DK161789A (fi)
ES (1) ES2097736T3 (fi)
FI (1) FI102547B1 (fi)
GB (1) GB8807921D0 (fi)
GR (1) GR3023353T3 (fi)
HU (1) HU204853B (fi)
IL (1) IL89734A (fi)
NO (1) NO177714C (fi)
PH (1) PH30960A (fi)
RU (2) RU1826970C (fi)
UA (1) UA26845C2 (fi)
ZA (1) ZA892188B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5093127A (en) * 1989-06-02 1992-03-03 Fujisawa Pharmaceutical Co., Ltd. Preparation of fr115224 substrate for parenteral administration
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0498069B1 (en) * 1990-12-21 1995-10-25 Fujisawa Pharmaceutical Co., Ltd. New use of peptide derivative
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
BRPI0807972A2 (pt) 2007-01-24 2014-06-10 Glaxo Group Ltd Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPS6424156A (en) * 1987-07-17 1989-01-26 Yanmar Diesel Engine Co Air-fuel ratio control device for gas engine
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
DK161789D0 (da) 1989-04-04
UA26845C2 (uk) 1999-12-29
DE68927759T2 (de) 1997-06-19
EP0336230A3 (en) 1991-07-17
JPH02204499A (ja) 1990-08-14
CN1036795A (zh) 1989-11-01
NO177714B (no) 1995-07-31
JP2551142B2 (ja) 1996-11-06
NO891389D0 (no) 1989-04-03
GR3023353T3 (en) 1997-08-29
KR890016061A (ko) 1989-11-28
DE68927759D1 (de) 1997-03-27
HU204853B (en) 1992-02-28
HUT49631A (en) 1989-10-30
RU1826970C (ru) 1993-07-07
KR0132567B1 (ko) 1998-04-14
ES2097736T3 (es) 1997-04-16
RU2043365C1 (ru) 1995-09-10
IL89734A0 (en) 1989-09-28
FI891581A (fi) 1989-10-06
IL89734A (en) 1994-05-30
FI102547B (fi) 1998-12-31
EP0336230A2 (en) 1989-10-11
PH30960A (en) 1997-12-23
ATE148890T1 (de) 1997-02-15
ZA892188B (en) 1989-11-29
AU3239789A (en) 1989-10-12
AU627453B2 (en) 1992-08-27
NO891389L (no) 1989-10-06
FI102547B1 (fi) 1998-12-31
EP0336230B1 (en) 1997-02-12
DK161789A (da) 1989-10-06
NO177714C (no) 1995-11-08
CN1037857C (zh) 1998-03-25
GB8807921D0 (en) 1988-05-05
CA1335662C (en) 1995-05-23

Similar Documents

Publication Publication Date Title
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
DE68909139D1 (de) Substanz FR901228 und deren Herstellung.
AU4869690A (en) Pyrazolopyridine compound and processes for preparation thereof
FI891581A0 (fi) Peptidderivat.
IL123551A0 (en) Tricyclic erythromycin derivatives
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
AU640241B2 (en) Ws7622a mono- or di-sulfate, process for preparation thereof and use thereof
AU7649391A (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.